Published on
June 1, 2020

Pure Extracts Corp | IPO Round

Who: Pure Extracts is positioned to be the premier commercialization and manufacturing partner for functional mushroom companies. The company is applying for a Dealers License with Health Canada and once approved will enable them to buy, sell, test and produce psychedelics in an EU GMP environment.

Financing Details:
- Raising C$5,000,000 at $0.30 per share
- Pre-Money Valuation of ~$16MM
- Anticipated CSE listing Q3, 2020 (Trade date + 4 month hold)

Request an Introduction to Pure


  • Pure has contracted $30MM in sales for first year of operations
  • 5 Years experience of volatile plant molecule extraction
  • Purpose-built EU GMP compliant facility, allowing for international distribution


  • Ben Nikolaevsky: CEO
  • Holds over a decade of experience in corporate leadership roles across the natural products, agriculture and cannabis sector.
  • Most recently President & CEO of Natura Naturals Inc., a privately held Canadian LP of cannabis that was acquired by Tilray Inc. (NASDAQ: TLRY) in February 2019.
  • Doug Benville: COO & Co-Founder
  • Master extractor with proven expertise in scalable formulas and processes.